Cover Image

Assisted Reproductive Technology Outcomes in Women with Normal Ovarian Response Receiving Recombinant Luteinizing Hormone/Human Menopausal Gonadotropin: An Observational Study

Yingxiu Liang,1 Xiaohong Hou,1 Haoying Chen,1 Ruqing Yang,1 Ruina Wang,1 Ruotong Mao,1 Junzhao Zhao,1 Hui Chen,2 Jing Cheng1 1Reproductive Center, Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zheji...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liang Y (Author), Hou X (Author), Chen H (Author), Yang R (Author), Wang R (Author), Mao R (Author), Zhao J (Author), Cheng J (Author)
Format:	Book
Published:	Dove Medical Press, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?
by: M. Kirshenbaum, et al.
Published: (2021)

Diminished ovarian reserve predisposes to premature luteinizing hormone surges in gonadotropin-releasing hormone antagonist cycles in In vitro fertilization
by: Puneet Kaur Kochhar, et al.
Published: (2020)

Urinary versus recombinant gonadotropins for ovarian stimulation in women undergoing treatment with assisted reproductive technology
by: Ameet Patki, et al.
Published: (2018)

Recombinant human luteinizing hormone increases endometrial thickness in women undergoing assisted fertility treatments: a systematic review and meta-analysis
by: Routong Mao, et al.
Published: (2024)

Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials
by: Alessandro Conforti, et al.
Published: (2021)

Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF
by: F. S. Mennini, et al.
Published: (2018)

The enigma of the gonadotropin-releasing hormone pulse frequency governing individual secretion of luteinizing hormone and follicle-stimulating hormone
by: Cornelis B. Lambalk, M.D., Ph.D
Published: (2023)

Highly sensitive in vitro bioassay for luteinizing hormone and chorionic gonadotropin allowing their measurement in plasma
by: Danièle Klett, et al.
Published: (2021)

RECOMBINANT HUMAN LUTEINIZING HORMONE FOR THE TREATMENT OF INFERTILITY: THE GENERATION OF PRODUCER CELL LINES
by: N. A. Orlova, et al.
Published: (2017)

A comparison of human chorionic gonadotropin and luteinizing hormone releasing hormone on the induction of spermiation and amplexus in the American toad (<it>Anaxyrus americanus</it>)
by: Kouba Andrew J, et al.
Published: (2012)

Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
by: Batool Hosein Rashidi, et al.
Published: (2019)

Supplementation with human menopausal gonadotropin in the gonadotropin-releasing hormone antagonist cycles of women with high AMH: Pregnancy outcomes and serial hormone levels
by: Liang-Hsuan Chen, et al.
Published: (2021)

Differential gene expression in human granulosa cells from recombinant FSH versus human menopausal gonadotropin ovarian stimulation protocols
by: Bietz Mandi G, et al.
Published: (2010)

Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness Analysis
by: Li H, et al.
Published: (2024)

CC-Human Menopausal Gonadotropin Combined with Growth Hormone in Mini-stimulation Protocol could Improve Clinical Outcome in Poor Ovarian Responders
by: Arie A Polim, et al.
Published: (2016)

Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination
by: Binarwan Halim, et al.
Published: (2022)

Activating and inactivating mutations of the human, rat, equine and eel luteinizing hormone/ chorionic gonadotropin receptors (LH/CGRs)
by: Kwan-Sik Min, et al.
Published: (2021)

Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome
by: Liu Nana, et al.
Published: (2012)

Pre-ovulatory hormones on day of human chorionic gonadotropin trigger and assisted reproductive technique outcomes in different ovarian response groups
by: Subarna Mitra, et al.
Published: (2021)

Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden
by: Wex J, et al.
Published: (2013)

Long-Acting Luteinizing Hormone-Releasing Hormone Agonist for Ovarian Hyperstimulation Induced by Tamoxifen for Breast Cancer
by: Nobue Kojima, et al.
Published: (2018)

Luteinizing hormone and follicle stimulating hormone synergy: A review of role in controlled ovarian hyper-stimulation
by: Gottumukkala Achyuta Rama Raju, et al.
Published: (2013)

Menopausal hormone therapy and ovarian cancer
by: Rod Baber
Published: (2015)

Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer
by: Emons Günter, et al.
Published: (2003)

Gonadotropin releasing hormone analogs as part of controlled ovarian stimulation
by: Richard Fleming, Ph.D
Published: (2023)

Involvement of Src family of kinases and cAMP phosphodiesterase in the luteinizing hormone/chorionic gonadotropin receptor-mediated signaling in the corpus luteum of monkey
by: Kunal Shah B, et al.
Published: (2012)

Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) /luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin/neurokinin B/dynorphin neurons in PCOS rats
by: Ge Xu, et al.
Published: (2023)

Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
by: Kuan-Hao Tsui, et al.
Published: (2014)

Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
by: Klaus F. Bühler, et al.
Published: (2021)

Pregnancy outcome in long- versus short-acting gonadotropin-releasing hormone agonist cycles in participants with normal ovarian reserve: An RCT
by: Roya Kabodmehri, et al.
Published: (2023)

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
by: Matteo Lambertini, et al.
Published: (2019)

The effect of luteinizing hormone changes in GnRH antagonist protocol on the outcome of controlled ovarian hyperstimulation and embryo transfer
by: Jing-Shuang Zhou, et al.
Published: (2023)

Effects of human menopausal gonadotropin on zona pellucida and pregnancy outcomes of ovarian stimulation protocols
by: Bing He, et al.
Published: (2015)

Comparison of the effect of two different doses of recombinant gonadotropin for ovarian stimulation on the outcome of intrauterine insemination
by: Ming-Ting Chung, et al.
Published: (2011)

Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
by: Hou L, et al.
Published: (2015)

Luteinizing hormone elevation in ovarian granulosa cell tumor: a case report and review of the literature
by: Shengyuan Ran, et al.
Published: (2017)

Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Precocious Puberty
by: Eren Er, et al.
Published: (2023)

The Expression of Serum Antibodies Against Gonadotropin-releasing Hormone (GnRH1), Progonadoliberin-2, Luteinizing Hormone (LH), and Related Receptors in Patients with Gastrointestinal Dysfunction or Diabetes Mellitus
by: Bodil Roth, et al.
Published: (2014)

The Expression of Serum Antibodies against Gonadotropin-releasing Hormone (GnRH1), Progonadoliberin-2, Luteinizing Hormone (LH), and Related Receptors in Patients with Gastrointestinal Dysfunction or Diabetes Mellitus
by: Bodil Roth, et al.
Published: (2014)

Comparative Pharmacokinetics, Bioequivalence and Safety Study of Two Recombinant Human Chorionic Gonadotropin Injections in Healthy Chinese Subjects
by: Wang J, et al.
Published: (2020)